Author: Kathir J

  • The Second Chu Culture Festival Opens in Jingzhou, China

    On the evening of September 20, the opening ceremony of the Second Chu Culture Festival was held in Jingzhou, China. The event was guided by the China Public Diplomacy Association, the China Federation of Cultural Promotion, and the Cultural Communication Committee of the China Cultural Management Association, hosted by the CPC Jingzhou Municipal Committee and the Jingzhou Municipal People’s Government, and organized by Hubei Radio and Television Station.

    Cultural scholars from home and abroad, diplomats from multiple countries stationed in China, international youth representatives, elite Chu entrepreneurs, figures from the literary and art circles, and Jingzhou citizens gathered together for a grand Chu culture celebration that bridged the ancient and the modern, blending China and the world.

    As an important component of the long-standing Chinese civilization, Jingchu culture holds a crucial place in its historical development. The Second Chu Culture Festival, themed “Let the World See Chu Culture”, seeks to vividly showcase the Yangtze River civilization through the inheritance and innovation of Chu culture. The festival aims to propel Jingchu culture “beyond its circle and across the seas,” enabling more people to appreciate the unique charm of Chinese and Yangtze River civilizations, to understand “Why Jingchu?” and “Why China?” through the glory of history and the reflection across millennia.

    The opening ceremony took Chu lacquerware, bamboo slips, and Chu embroidery as narrative threads, unfolding in three chapters: “Beautiful Jingzhou, Waiting in Lacquer”, “History on the Slips, Understanding China”, and “Splendid Rivers and Mountains, Robes of Unity.” These showcased three iconic cultural treasures from the land of Chu.

    The ceremony began with the Chu-style welcoming song-and-dance performance “Arrival of the Phoenix”, recreating the grandeur of ancient Chu welcoming rituals with graceful ceremonies and elegant dances. On the large stage screen, phoenix feathers extended toward the audience, and light and shadow evoked the majestic vision of “A phoenix sings over Chu, soaring across the heavens.”

    Three unique “treasures” were unveiled, integrating national-level cultural relics with modern technology to interpret the profound legacy of Chu culture.

    The first treasure, the painted wooden lacquer artifact Toad-Base Phoenix Bird with Feathered Man, made a stunning debut. Aerospace film director Zhu Yiran, polar explorer He Pengfei, and aerospace new-material researcher Cao Genyang each took the stage to share insights inspired by this relic—through film clips, polar experiences, and even a “stone-carved moon flag.” In their narratives, the Chu artifact became a living cultural messenger, breathing romance and grandeur.

    The second treasure, the Chu bamboo slips, was equally awe-inspiring. Renowned cultural scholar Xiong Zhaozheng, appearing as a “Guardian of Yangtze Culture,” explained that “The Chu slips are a cultural gene living in the present.” He called upon future generations to “continue writing the archive.” Then, Zhang Han, a young Jingzhou-born dancer, performed the martial arts piece “One Slip, A Thousand Years”, using a blend of strength and grace to bring Chu script to life and demonstrate the contemporary inheritance of cultural bloodlines.

    The third treasure focused on the artistry of Chu embroidery. Jingzhou-born actress and Chu culture ambassador Zeng Li warmly introduced Chu silk in her local dialect: “It is light, as light as cicada wings; it is heavy, carrying over two thousand years of time.” Following this, the Warring States robe showcase “Splendid Rivers and Mountains” featured exquisitely recreated Chu garments, allowing the audience to travel back in time to experience Chu people’s aesthetic wisdom and lifestyle beauty.

    The opening ceremony also carried strong international elements. A launch event titled “Latin America and the Caribbean Delegation in Jingzhou” was held, where representatives from 16 countries jointly raised a symbolic key of friendship and cooperation to unlock Jingzhou’s ancient yet modern charm. During the festival, they will experience the deep fusion of “Jingchu Spirit” and “Latin American Passion.”

    Another highlight was the flag presentation ceremony for the “First International Youth Yangtze Journey.” Guests from China and abroad presented flags to outstanding young representatives from 13 countries including Argentina, Brazil, Egypt, and Hungary, who will embark on a journey from Jingzhou along the Yangtze River to better understand China.

    The entire opening ceremony was a visual and auditory feast. The opening dance “Arrival of the Phoenix” showcased the beauty of Eastern etiquette through grand Chu-style rituals; “The Spirit of Lacquer” expressed the elegance of lacquerware through graceful movements; and the mass recitation “Echoes of Millennia” resounded with powerful voices that stirred hearts.

    In the finale, inspired by the camel-rider lamp—an iconic artifact symbolizing Chu people’s external exchanges—Chinese and international guests together lit the “Lamp of Inheritance,” the “Lamp of Friendship,” the “Lamp of Peace,” and the “Lamp of Civilization,” symbolizing mutual learning and everlasting friendship. The closing performance “Let the World See” brought the atmosphere to its peak, conveying Jingzhou’s firm confidence in connecting the world through culture and opening the future through innovation.

    During the festival, eight major themed sections with more than 20 activities will be held, covering cultural exchange, academic seminars, public performances, and business cooperation. Highlights include the “Chu Merchants Homecoming and Jingzhou 2025 Chu Business Conference & Major Project Signing,” the CCTV “Bosom Friends Hubei · Chu Charm Jingzhou” Autumn Concert, the “Most Beautiful Warring States Robe Travel Photography Season” awards, the “Yijing Jing’en Intangible Heritage Exhibition and Performance,” and the “Brilliant Yangtze” Eastern Zhou Archaeology Exhibition. These events will present Jingzhou’s deep historical heritage and modern vitality to the world.

    By gathering momentum through the festival, leveraging it as a bridge, empowering development, and benefiting the people, Jingzhou is focusing on building a strong regional hub. Through the festival as a breakthrough point, the city promotes the study, interpretation, and dissemination of Chu culture, continually advancing its protection, inheritance, and global reach. Jingzhou is committed to becoming an authoritative center for interpreting Chu culture in the new era, a stage for immersive experiences, a hub of activities, and a destination for cultural tourism—enhancing its cultural influence and contributing strong momentum to “building a pioneering area and being a vanguard.”

  • Zeagoo’s 12th Anniversary Grand Collaboration with Maye Musk: Early Autumn Fashion Guide First Release

    As early autumn arrives, the global women’s apparel brand Zeagoo celebrates its 12th Anniversary. Since its founding, Zeagoo has always stood by “Be Different, Be You,’”upholding its mission to create comfortable and fashionable apparel for mature women. It aims to convey a brand philosophy of easy, comfortable self-expression and self-realization.

    At this landmark moment, Zeagoo officially announces September 22nd as its 12th Anniversary celebration day. This celebration is highlighted by the launch of the “Zeagoo X Maye Musk’”2025 Early Autumn Zeagoo Fall Style Guide, a collaboration with the internationally renowned model, Doctor of Dietetics, and entrepreneur, Maye Musk. The guide helps women aged 35+ discover comfortable, stylish, and inspiring outfit ideas.

    Maye Musk: A Paragon of Independent Women

    At over 70, Maye Musk is a globally acclaimed supermodel, Doctor of Dietetics, and entrepreneur who has broken conventional perceptions of age. Her independent and resilient spirit aligns perfectly with Zeagoo’s philosophy. Zeagoo has always focused on the diverse needs of women aged 35+, whether they require professional looks for the workplace, comfortable wear for daily life, or unique styles for social events.

    Reflecting on her own journey through those years, Maye quickly accepted the collaboration, stating, “These designs are for women 35+. When I was that age and older, I needed to look stylish on a small budget. These clothes would’ve been perfect for me. Thank you, Zeagoo, for caring for us.” This collaboration is a union of shared values, aiming to guide more women to find their own path where comfort and style.

    MayeMusk Picks:  Early Autumn Staples

    In the “Zeagoo X Maye Musk” 2025 Early Autumn Zeagoo Style Guide, Maye Musk has carefully selected several comfortable and stylish pieces, including outerwear, a top, and a skirt. These items cater to the diverse early autumn needs of women aged 35+, with each one showcasing Zeagoo’s exceptional craftsmanship and stylish design.

    Item 1: Zeagoo Women’s Zip Up Hoodies Oversized Fleece Long Tunic Sweatshirts

    This full-zip hoodie is an essential piece for any early autumn wardrobe. Not only has it been featured in Maye’s fall favorites recommendations from Zeagoo, but it has also received official recognition—it was specifically recommended as a top fashion pick for moms on the FOX29 Good Day Philadelphia segment, ‘Back-to-School Must-Haves.’

    • Comfortable Fabric:Elastic fleece material is skin-friendly and breathable, allowing for unrestricted movement.
    • Versatile Wearing: The knee-length full-zip design enables multiple styling options, such as a jacket or an overlayer, for effortless style transitions.
    • Practical Design: The oversized fit with large pockets combines personality and functionality.

    Item 2: Zeagoo Womens 2025 Fall Sweaters

    With its soft texture and stylish design, this Zeagoo knit sweater is a perfect addition to your Zeagoo Fall Style—ideal for both layering and solo wear in early autumn. It’s also featured in Maye’s fall favorites from Zeagoo.Premium Material: A soft, lightweight, and breathable blend of viscose, polyester, and polyamide for lasting comfort and a flattering fit.

    • Chic Design: Features a loose fit and V-neck that elongates the neck, with detailed lantern sleeves, cable-knit, and hollow-out patterns for added texture and style.
    • Versatile Styling: Perfect for both professional and casual settings. Wear it solo or layered, and pair it with various bottoms—ideal for work, meetings, or outings.

    Item 3: Zeagoo Skirts for Women High Waist Skirt Elegant Midi Skirt Satin

    This skirt, with its premium material and slimming design, is a key piece for elevating any early autumn outfit.

    • Material & Fit: Made of skin-friendly, breathable satin with mid-weight thickness ideal for early autumn. Available in maxi and midi lengths to suit different body types.
    • Slimming Design:High-waisted cut visually elongates the figure and enhances curves. The minimalist design exudes elegant maturity suitable for various occasions.
    • Styling Options: Easily paired with boots and sweaters in autumn/winter, or sandals and camisoles in warmer months. Perfect for daily wear, work, parties, and vacations.

    Dual-Channel Celebration: Thanking Our Companions, Embracing the Future

    Celebrating Zeagoo 12th Anniversary, the brand hosts the American Dreams Hot Sale and launches the new Zeagoo Fall Style Guide with Maye Musk.

    From September 19–20, Zeagoo opens the American Dreams Hot Sale pop-up at the American Dream Mall atrium in New Jersey, featuring collaborations with EKOUAER, COOFANDY, Arshiner, and PINSPARK for an immersive in-person shopping experience.

    Zeagoo remains committed to its core philosophy, “Be Different, Be You,” and its original mission to create comfortable and stylish apparel for mature women. From the impactful collaboration with Maye Musk to the special anniversary events, Zeagoo is dedicated to empowering women aged 35+ worldwide, enabling them to confidently express themselves in every aspect of life and convey their charm through their fashion choices.

    For more information, please visit the Zeagoo website and Amazon storefront, or connect with Zeagoo on Facebook and Instagram.

    Zeagoo

    Charlotte Liu

    pr@zeagoo.com

    New York, US

    https://zeagoo.com

  • China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies

    China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies

     

    SHENZHEN, CHINAChina Medical System Holdings Limited (CMSor the Group) is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the “Agreements”) with Chongqing Genrix Biopharmaceutical Co., Ltd. (“Genrix Bio”) for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, “Vecantoxatug”) indicated for passive immunization against tetanus and Silevimig Injection (GR1801, “Silevimig”) indicated for passive immunization following suspected rabies virus exposure, respectively. In accordance with the Agreements, the Group has obtained exclusive commercialization rights for these two products in mainland China and exclusive licensing rights for the rest of the Asia-Pacific region, the Middle East and North Africa. The collaboration terms respectively extend until ten years after these two products receive their marketing approvals in Mainland China (the “Initial Term for each Product”). Unless terminated or dissolved under the terms set forth in the Agreements, the Agreements will automatically renew for successive ten-year periods upon expiration of the Initial Term for each Product.

     

    Vecantoxatug is a passive immunization agent with an excellent safety profile, which delivers superior protection compared with human tetanus immunoglobulin (HTIG), providing rapid and durable immune defense for patients. Its Phase III clinical trial for passive immunization against tetanus successfully met the primary efficacy endpoint. In May 2024, Vecantoxatug was designated Breakthrough Therapy by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). On 22 May 2025, its New Drug Application (NDA) was formally accepted by the CDE.

     

    Silevimig is the world’s first recombinant, fully human bispecific antibody against rabies virus (RABV) targeting epitope I and/or epitope III of the rabies virus glycoprotein, developed in accordance with the World Health Organization (WHO) recommended “cocktail” therapeutic option targeting distinct antigenic sites. It can be manufactured at scale with standardized, and also demonstrates broad neutralization, low immunogenicity, minimal interference with vaccine-induced active immunity, and controlled production cost. On 14 January 2025, its NDA for use in adults requiring passive immunization following suspected rabies virus exposure was formally accepted by CDE. In addition, in July 2025, the NMPA approved the clinical trial application for Silevimig in children and adolescents aged 2 to <18 years requiring passive immunization following suspected rabies virus exposure. This Phase III clinical trial is currently in progress.

     

    CMS has always been committed to deploying innovative products with clinical value and differentiated advantages. The market for tetanus and rabies passive immunization remains substantial, yet existing passive immunization products are constrained by safety and accessibility concerns. If approved, Vecantoxatug and Silevimig will provide new preventive and therapeutic options of passive immunization for patients following tetanus and rabies exposure. Additionally, they will synergize with the Group’s existing products in expert networks and market resources, bringing benefit to patients.

     

    More information about Vecantoxatug and Tetanus

    Vecantoxatug is a recombinant humanized monoclonal antibody against tetanus neurotoxin (TeNT), which is self-developed by Genrix Bio. Vecantoxatug binds to the fragment C domain of the TeNT heavy chain (TeNT-Hc).  TeNT is an about 150 kDa single-chain protein that undergoes post-translational modification to form an active toxin composed of heavy and light chains. By specifically binding TeNT-Hc, Vecantoxatug effectively blocks toxin entry into neurons, providing passive immunization. The patent for Vecantoxatug has been granted in China.

     

    Tetanus is an acute and specifical infection caused by Clostridium tetani (C. tetani) entering the body through wounds. It affects individuals across all age groups and, in the absence of medical intervention, is almost universally fatal-particularly among infants and the elderly. Even with active treatment, global mortality remains as high as 30-50%, with an estimated 500,000 to 1,000,000 cases reported annually worldwide[1].

     

    C. tetani is ubiquitous in soil and the environment, and is also present in the intestines of mammals. As the pathogen invades through skin or mucosal injuries, causing the acute and specifical infection, prevention remains the most effective strategy. Currently available passive immunization agents, commonly known as tetanus shot, – tetanus antitoxin (TAT), equine-derived tetanus immunoglobulin (F(ab’)₂), and human tetanus immunoglobulin (HTIG) – face notable limitations in safety and accessibility[2], including risks of allergic reactions, potential infectious pathogen transmission, and limited availability. Consequently, there remains a pressing clinical need for new preventive and therapeutic options. Vecantoxatug is able to provide greater protection than HTIG, while demonstrating excellent safety, tolerability, and low immunogenicity. With enhanced controllability and accessibility, Vecantoxatug has the potential to offer patients an advanced preventive and therapeutic option.

     

    More information about Silevimig and Rabies

    Silevimig is a recombinant, fully human bispecific antibody against rabies virus, which is self-developed by Genrix Bio. It targets the viral envelope glycoprotein (G protein) of RABV and blocks its interaction with host receptors by binding to epitopes I and/or III. Through this mechanism, Silevimig prevents RABV from invading neural tissue prior to the establishment of full protection by active rabies vaccination, thereby helping to prevent rabies infection. Silevimig’s molecular design is consistent with the recommendations of the WHO for anti-RABV antibody development, which emphasize the use of “cocktail” combinations of monoclonal antibodies targeting distinct antigenic sites to ensure broad effectiveness across different viral strains and genotypes. The patent for Silevimig has been granted in China.

     

    In a Phase III clinical trial for post-exposure passive immunization in adults, Silevimig met its primary efficacy endpoint, demonstrating non-inferior protective efficacy compared with human rabies immunoglobulin (HRIG), the currently most used passive immunization product in China. The study confirmed that Silevimig provides immediate protection during the early stages of rabies virus exposure without compromising the active immune response induced by vaccination.

     

    Rabies is an acute zoonotic disease caused by RABV, clinically characterized by hydrophobia, aerophobia, pharyngeal muscle spasms, and progressive paralysis[3]. With a case-fatality rate approaching 100%, it is one of the deadliest diseases worldwide. At present, there is no proven treatment for rabies once clinical symptoms appear. Standardized Post-Exposure Prophylaxis (PEP), comprising wound care, vaccination, and passive immunization administered as needed, remains the most effective rabies prevention strategy[4]. As vaccine-induced antibodies require 1–2 weeks after the first dose of vaccine injection, to reach protective levels (≥0.5 IU/mL), passive immunization provides immediate coverage during this high-risk window[3]. According to the the National Regulation for the Rabies Exposure Prophylaxis (2023 Edition), patients with Category III exposure and those with severe immunodeficiency and Category II exposure should receive passive immunization at the same time as the first dose of rabies vaccine[5]. In China, more than 40 million people are exposed to rabies annually, of whom approximately 40% (16 million) fall under Category III exposure[3]. However, due to factors such as limited awareness, high cost, and restricted accessibility, only about 15% of Category III cases receive passive immunization[3].

     

    Currently approved passive immunization options in China include human rabies immunoglobulin (HRIG) and equine rabies antiserum (ERA), both of which provide immediate protection by preventing viral entry into neural tissue. HRIG must be sourced from repeatedly immunized healthy donors, making it difficult and costly to obtain. And it is associated with potential risks of blood-borne infections (e.g., HIV, hepatitis B, hepatitis C). ERA, being a heterologous protein, is prone to adverse reactions such as serum sickness and anaphylactic shock[3]. Beyond HRIG and ERA, only two rabies antibody products have been approved in China to date. Silevimig is the worlds first recombinant, fully human bispecific antibody for passive immunization against rabies, which is consistent with the WHO recommended cocktail approach. Its approval is expected to provide patients with broad and robust protection.

     

    About GENRIX BIO

    Genrix Bio (Stock Code: 688443), founded in 2015, is an innovative biopharmaceutical company driven by advanced antibody drug discovery technology to address critical clinical needs. Genrix Bio is committed to the development of monoclonal and bispecific antibodies for autoimmune diseases, infectious diseases, and oncology. Its capabilities span across antibody molecular discovery, process development and quality research, clinical trials, and large-scale commercialization. Learn more about Genrix Bio and its products at https://www.genrixbio.com/

     

    About CMS

    CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

     

    CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

     

    CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in the Southeast Asia and Middle East regions, further escorting the sustainable and healthy development.

     

    Reference:

    1. China Trauma Rescue and Treatment Association. Peking University Trauma Medicine Center. Chinese expert consensus on tetanus immunization[J]. Chinese Journal of Surgery,2018,56(3):161-167. DOI: 10.3760/cma.j.issn.0529-5815.2018.03.001
    2. Members of the Emergency Surgery Committee of Chinese College of Emergency Physicians, Members of the Emergency Medicine Committee of the People’s Liberation Army, Beijing Society for Emergency Medicine, et al. Expert consensus on prophylaxis, diagnosis and management of tetanus among adults[J]. Journal of Clinical Emergency, 2018, 19(12):801-811. DOI: 10.13201/j.issn.1009-5918.2018.12.001
    3. Chinese Center for Disease Control and Prevention. Technical Guidelines for Human Rabies Prevention and Control (2016). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P02024090652542…
    4. Yin Wenwu, Wang Chuanlin, et al. Expert consensus on rabies exposure prophylaxis[J]. Chinese Journal of Preventive Medicine, 2019,53(7):668-679. DOI:10.3760/cma.j.issn.0253-9624.2019.07.004
    5. Chinese Center for Disease Control and Prevention. The National Regulation for the Rabies Exposure Prophylaxis (2023 Edition). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P02024090652542…

     

    CMS Disclaimer and Forward-Looking Statements

    This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

     

    This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

     

    Media Contact

    Brand: China Medical System Holdings Ltd.

    Contact: CMS Investor Relations

    Email: ir@cms.net.cn

    Website: https://web.cms.net.cn/en/home/

  • Ealing Council Exposed by Using Legal Processes for Improper Motives on Housing Disrepair Case Abuses its Resident Almost 4 Years Ago

    Advice Resolutions furthered their client’s concerns had which are previously mentioned of almost 4 years ago on the Housing Disrepair being reported to Ealing Council in November 2021 as follows:

    The issue of the brickwork pointing had already been addressed on December 1, 2021, when Ealing Council enlisted the joint visit to the resident’s home from Niblock contractors. From that visit of December 1, 2021, to the resident’s home which Ealing Council were aware of a report. On visual inspection at which the representative from Advice Resolutions was in attendance with their client. It was very evidence of the failure of the brickwork pointing. Ealing Council totally ignored the internal of the dwelling bungalow demise is most deteriorating also including further damage to the fixtures and fittings to the brickwork vent in the living room, and worsening damp, and mould both in the living room and bedroom almost 4 years ago since November 2021.

    Ealing Council being exposed on the Housing Disrepair Case linked to Knapp Hicks and Partners totally ignored the brickwork issue since November 2021 in their own omissions to cover up the previous housing disrepair complaint and abusing its resident almost 4 years ago. Ealing Council used key legal processes for improper motives as retaliation by covering up the complaint and wanting to silence the Claimant by abusing him also in their attempt to committed murder by wanting to keep him as a hostage inside the damp property by concealing their criminality are freemasons behaving like mafia gangsters in the league by siding with slum landlords using corruption, fraud, and racketeering such as Al Capone of the 1930s also accepting kickbacks by offering bribes and/or soliciting bribes.

    Conclusion

    Ealing Council as the corporate cannot be given no excuse by delaying the rectification of such repairs to the brickwork pointing to the property are bunch of very dirty racists breached the Equality Act 2010 under Section 149. The Council therefore cannot use the recent survey on August 28, 2025, by making excuses and lying in court on the housing disrepair since November 2021 using trickery and being deceitful as the corporation organization cannot be trusted with their professional reputation being damaged as a result.

    https://www.standard.co.uk/news/london/tenant-rats-mould-home-northolt-e…

    https://www.harrowonline.org/2025/03/09/northolt-resident-says-council-d…

    https://www.amazon.co.uk/Years-Housing-Criminal-Landlord-1997-2020/dp/BO…

    Video : https://www.youtube.com/watch?v=h98lhz7siJY

    Media Contact: 

    Errol Baptiste
    Errol Baptiste’s YouTube Channel
    Northolt/Ealing
    Middlesex
    United Kingdom
    07598782045
    errolbaptiste@hotmail.com
    www.youtube.com/@errolbaptiste

  • Self-Reform is strength: Why the Eight-Point Decision matters in China

    Soon, China will be celebrating the annual Mid-Autumn Festival. Mooncakes, the traditional Chinese treat for this special occasion, have become all the rage again like they are every year around this time. Each year, tens of billions of yuan’s worth of mooncakes are sold.

    Where there is no check on power, there could be corruption and misconduct. Once, various flavors of mooncakes made of expensive ingredients became favored gifts, used for gratification and to curry favor at what was supposed to be a family-oriented festival season.

    That was put to a stop by the Eight-Point Decision – sets of rules implemented to improve the Communist Party of China’s (CPC) conduct, curb unnecessary formalities, bureaucracy, hedonism and extravagance. Mooncake products worth more than 500 yuan (or more than $70) are heavily monitored. What had been traditionally consumed as a celebration resumed its original functionality. Mooncakes are once again for family, not personal advancement.

    It may seem mundane, but this “mooncake incident” is a reflection of what has become a nation-wide, long-term and consistent campaign by the CPC to advance full and rigorous self-governance. The Eight-Point Decision was first adopted in 2012 by the Party leadership to address chronic bureaucratic issues. Later, it was expanded into a Party-wide initiative for all members to adopt its principles to improve governance conduct.

    As Chinese President Xi Jinping emphasized in June, 2025, advancing Chinese modernization is a formidable task, and the Party faces an exceptionally complex governance environment, making it all the more necessary to maintain a heightened sense of self-reform. Carrying out the Eight-Point Decision is not just about combating corruption in the narrow sense of misuse of power, but about strengthening political integrity.

    Misconduct and corruption on people’s doorsteps are the most strongly felt and despised. The Eight-Point Decision is adopted so that both could be addressed at the same time. In the decade following the implementation of the Eight-Point Decision, more than 1.1 million people were reminded, reprimanded or punished for violating the rules. Some of the most senior officials, including former members of the Political Bureau and its Standing Committee, top military brass and retirees, have been investigated and brought to justice for their practices.

    Lavish banquets, personal use of official vehicles or other symbolic perks of officialdom have largely faded; government departments and agencies stepped up transparency with regular disclosure of expenses; administrative services are streamlined with greatly improved efficiency; private companies could finally forgo the “personal-connection-business-model” and turn their resources and focus to innovation and greater development.

    What is noteworthy is how the Eight-Point Decision has evolved from a disciplinary measure into a framework for building lasting systems of governance. It is not a one-off restraint, but it is institutionalizing a culture of accountability and standardization. By embedding rules into everyday governance—whether through digital platforms that track official expenses, or through streamlined approval procedures that cut redundant paperwork—the CPC is improving its systemic rule-based governance.

    This process has gradually reshaped expectations across society. For officials, it sets clear boundaries of conduct and creates a rule-conscious mindset. For enterprises, it levels the playing field, reducing the hidden costs once needed to navigate opaque channels. For ordinary citizens, it signals that the government’s promises of fairness and efficiency are backed by enforceable rules. In this sense, the Eight-Point Decision is less about restraining extravagance during festivals, and more about solidifying a governance model that is transparent, predictable, and people-centered.

    As China continues to advance modernization, such system- and rule-building will be crucial in ensuring that governance keeps pace with social and economic transformation – turning individual measures into long-term institutions that underpin stability and trust.

    https://news.cgtn.com/news/2025-09-22/Self-Reform-is-strength-Why-the-Eight-Point-Decision-matters-in-China-1GRPUNOd5jW/p.html

  • Xinjiang takes giant strides at 70

    With this year marking the 70th anniversary of the founding of Xinjiang Uygur Autonomous Region in northwest China, China’s State Council Information Office on Friday released a white paper titled “CPC Guidelines for Governing Xinjiang in the New Era: Practice and Achievements.”

    Over seven decades, Xinjiang has evolved from a remote and underdeveloped frontier into a vibrant hub of economic growth, cultural diversity, and social stability. The 70th anniversary not only honors the autonomous region’s accomplishments but also reaffirms China’s commitment to safeguarding ethnic unity, advancing regional prosperity, and promoting long-term harmony.

    Since its founding, Xinjiang’s journey has been marked by remarkable economic progress that has lifted millions out of poverty and turned the region into a crucial economic engine.

    With rich natural resources including oil, gas, and minerals, Xinjiang has benefited from integrated development strategies that balance industrial expansion with sustainable resource utilization. Infrastructure upgrades – from high-speed railways connecting Xinjiang to inland provinces to modern highways and airports – have spurred connectivity and trade, facilitating Xinjiang’s role as a gateway in the Belt and Road Initiative.

    The region’s GDP has grown steadily, reflecting diversified industries including energy, agriculture, manufacturing, and tourism. Last year, Xinjiang’s GDP topped 2 trillion yuan ($278 billion) for the first time, marking a 6.1 percent year-on-year growth.

    Beyond economic success, Xinjiang’s social fabric exemplifies ethnic unity and flourishing of diverse cultures. With 56 ethnic groups living in the region, Xinjiang is a harmonious multi-ethnic society, with policies that protect cultural heritage while fostering socioeconomic integration.

    The region has invested heavily in education, healthcare, and social welfare, ensuring equitable development opportunities across ethnic lines. “Fostering a stronger sense of the Chinese nation as one community” was listed as a guideline in the white paper.

    Efforts to preserve minority languages and traditions empower local communities to participate in social and economic life, reinforcing the spirit of mutual respect and shared destiny. Between 2010 and 2018, the Uygur population in Xinjiang grew by 25.04 percent, exceeding the growth rate of the Han population in Xinjiang by 23 percentage points.

    Religious freedom is well protected by law. Xinjiang is home to nearly 25,000 religious venues including mosques, churches and Buddhist temples – evidence of religious freedom in the region.

    Another critical dimension of Xinjiang’s achievements is the greatly enhanced public security and social stability that underpin its development. Upholding social stability and lasting peace and security is the overall goal of the work related to Xinjiang, according to the white paper.

    Amid the complex challenges posed by extremism and separatism, the government has implemented comprehensive measures emphasizing law-based governance and community engagement.

    These actions have restored peace and order, facilitating an environment where all residents can live and work safely. The resulting stability has been essential for attracting investment, building infrastructure, and improving the quality of life – core preconditions for sustainable development.

    Environmentally, Xinjiang has expanded its oasis areas by 56,000 square kilometers, simultaneously reducing desertified land by nearly 2,000 square kilometers and decreasing the frequency of sandstorms by 14 percent over the past decade.

    These achievements demonstrate the efficacy of China’s political system of regional ethnic autonomy. The 70th anniversary serves as both a celebration of achievements and a call to advance high-quality growth.

    The story of Xinjiang is a testament to China’s path toward comprehensive modernization and rejuvenation.

    https://news.cgtn.com/news/2025-09-21/Xinjiang-takes-giant-strides-at-70-1GOytrUnkNG/p.html

  • BalanceLP Secures Strategic Incubation from Mechanism Capital, Core Testing Concludes Ahead of Global Launch

    September 17, 2025 – BalanceLP, the innovative protocol dedicated to “reshaping fair liquidity in DeFi,” has officially announced a strategic incubation and investment partnership with the internationally renowned blockchain investment firm Mechanism Capital. Together, the two parties will advance the development of a fair liquidity ecosystem in DeFi. With its core functionality testing now fully completed, BalanceLP has met all technical and security benchmarks required for launch and is preparing to open its services to Web3 users worldwide—ushering in a new phase of decentralized liquidity management.

    Tackling Industry Pain Points with Technology-Driven Fairness

    Since inception, BalanceLP has focused squarely on addressing DeFi’s structural issues: unfair entry timing, yield monopolization by whales, and fragile liquidity pools. The team pioneered an intelligent balancing algorithm to dynamically optimize liquidity distribution, designed a multi-tier reward model to ensure fair compensation for LPs of all sizes, and built an adaptive reserve mechanism to safeguard user capital during extreme market conditions. These innovations, validated through multiple real-world testing scenarios, directly resolve the “lack of fairness” and “lack of security” challenges faced by everyday DeFi participants.

     

    Strengthening Foundations with Mechanism Capital

    Recognizing BalanceLP’s innovative value and technological potential, Mechanism Capital has entered into a deep collaboration. Over the past six months, the two teams have focused on security and user experience:

    • Optimizing the protocol’s underlying architecture to enhance responsiveness and stability.
    • Securing multi-layer audits of core smart contracts by CertiK, SlowMist, and Quantstamp, ensuring no critical vulnerabilities remain.
    • Conducting a comprehensive adaptation to Binance Smart Chain (BSC), lowering the technical barriers for new participants.

    Comprehensive Testing Completed, Launch-Ready

    Leveraging Mechanism Capital’s resources, BalanceLP has conducted end-to-end testing across all critical scenarios:

    • Security: Over 200 rounds of stress testing on BSC for yield settlements and liquidity pool operations, with TPS consistently meeting top industry standards.
    • User Experience: Streamlined wallet integration with one-click access for mainstream Web3 wallets, compressing the full LP journey—“become an LP, track yields, redeem funds”—into just 3–5 steps.
    • Transparency: Every operation is recorded on-chain in real time, enabling users to verify transaction details and trace fund flows via hash queries.

    With all testing phases concluded, BalanceLP is fully prepared for launch.

    Joint Commitment: Driving Fairness in DeFi

    A Director at Mechanism Capital commented:“BalanceLP’s technology addresses DeFi’s fairness challenges head-on. Its user-centric vision aligns with our mission of empowering high-quality infrastructure. We will continue to provide capital, institutional liquidity, and compliance advisory to help BalanceLP become the benchmark for fair liquidity.”

    The Founder of BalanceLP added:“We appreciate Mechanism Capital’s trust and the community’s support. The upcoming launch will deliver low-barrier participation, fair rewards, and strong security assurances. Based on community feedback, we will iterate further—first focusing on the BSC ecosystem, then progressively expanding toward multi-chain liquidity integration.”

    With comprehensive testing concluded and strong institutional backing, BalanceLP is set to roll out globally, bringing Web3 users a fairer and safer DeFi liquidity experience while providing a practical model for fairness in the decentralized finance industry.

    Disclaimer: All news, information, and other content published on this website are provided by third-party brands or individuals and are for reference and informational purposes only. They do not constitute any investment advice or other commercial advice. For matters involving investment, finance, or digital assets, readers should make their own judgments and assume all risks. This website and its operators shall not be liable for any direct or indirect losses arising from reliance on or use of the content published herein.

  • Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches ‘Global Open Innovation’ for U.S. Startups

    Seoul Bio Hub and Celltrion Launch Strategic Gateway ‘Global Open Innovation’ to Help U.S. Bio Startups Dominate the Asian Market

    Two U.S.-Based Biotech and Medical Device Startups to Be Selected Based on Technology Alignment with Celltrion’s Expertise in Antibodies, Peptides, and Drug Formulation

    Seoul, Korea – 17/09/2025 – (SeaPRwire) – Seoul’s bio startup hub ‘Seoul Bio Hub’ and global pharmaceutical leader ‘Celltrion’ have joined forces to launch the ‘2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)’ program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market.

    This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies.

    The application deadline is September 30, 2025. The selection process will proceed in the following order:

    • Primary document evaluation
    • Technology review
    • Secondary presentation evaluation.

    The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea’s innovative ecosystem and global capabilities.

    A Seoul Bio Hub representative stated, “This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul’s excellent clinical infrastructure and research environment.”

    A Celltrion representative announced, “Based on Celltrion’s capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company.”

    South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea’s biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally.

    Additionally, market research firm Grand View Research forecasts that South Korea’s biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%.

    Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem.

    According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade.

    South Korea’s Ministry of Health and Welfare has set ‘Achieving Global 3rd Place in Clinical Trials’ as a policy objective through the ‘3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)’. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the ‘Bio Health Mega Fund’ and is actively supporting innovative companies’ clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes.

    Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success.

    Celltrion is South Korea’s global comprehensive biotechnology company that developed the world’s first antibody biosimilar ‘Remsima’. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies.

    For detailed information regarding program applications and inquiries, please access LinkedIn, search for ‘Seoul Bio Hub’, and check the 2025 Seoul Bio Hub-Celltrion Global Open Innovation recruitment announcement posted on the official company page.

    About Seoul Bio Hub

    https://www.seoulbiohub.kr/front/user/engmain.do

    Establishment Date: October 30, 2017

    Operating Entity: Established by Seoul City / Joint operation by KIST and Korea University

    Location: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea

    Purpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 years

    Tenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%))

    Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale)

    Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitals

    Major Support Programs:

    • IR matching and investment linkage
    • Expert consulting and CEO education
    • Hospital-linked clinical and data programs
    • Open innovation with domestic and international pharmaceutical companies

    About Celltrion

    https://www.celltrion.com/en-us

    Establishment Date: February 26, 2002

    Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of Korea

    Business Areas and Major Products (Services)

    Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business Process

    • Remsima: World’s first monoclonal antibody biosimilar (TNF-α inhibitor)
    • Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatment
    • Truxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.)
    • Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercialization

    No of Employees: Approx. 3,003 (As of June 30, 2025)

    Media Contact

    Brand: SEOUL BIO HUB

    Contact: Lee Yoon Jin

    Phone: +82 02-2200-3345

    Email: lynj@kist.re.kr

    Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do;

    (ENG) https://www.seoulbiohub.kr/front/user/engmain.do

  • No Barriers, a Thousand Lights Shining on Each Other: Diverse Cultures Meet Equally in the Light and Shadow of the Golden Panda Awards

    China News Service, Chengdu, September 14 (Reporter He Shaoqing) Former Greek Prime Minister George Papandreou took out a panda doll named “Huahua” from his pocket; an American director interpreted giant pandas from the perspective of Chinese philosophy; filmmakers from across the globe traveled over mountains and seas to listen to and see one another… From September 12 to 13, diverse cultures met on an equal footing in the light and shadow of the 2nd Golden Panda Awards.

    In 1895, the Lumière brothers of France held the first public screening of short films such as Arrival of a Train in a basement in Paris. Since then, cinema—an art form that relies on light, shadow and time-space, and integrates audio-visual expressions with narratives—has come into existence. In 1925, the world’s first mechanical television set was invented. Film and television have not only reshaped human entertainment and daily life, but also played a profound role in the construction of modern civilization.

    Compared with the thousands of film festivals and TV/film exhibitions worldwide, the Golden Panda Awards has broken the boundaries of genre and region since its inception, covering four major categories: films, TV dramas, animations and documentaries. For the 2nd Golden Panda Awards, overseas works accounted for 73.2% of all collected entries, and nearly half of the judges were from outside China.

    On the evening of the 13th, 27 awards of the 2nd Golden Panda Awards were announced one after another in the “Land of Abundance” (a traditional name for Sichuan Province). Darlene Veenstra, a 77-year-old Brazilian actress, won the Best Actress Award in the Film Category for her courage to break societal norms; French editor Thomas Mali took home the Best Editing Award in the Documentary Category for Memories of WWⅡ, a work that urges mankind to remember history; the late Chinese director Pema Tseden was awarded the Best Director Award in the Film Category for his film Snow Leopard

    Free from the pursuit of popularity and the urge to cater to the market, the 27 Golden Panda Awards embody the empathy of all humanity toward light and shadow, and vividly illustrate the concept that different cultures can coexist harmoniously while preserving their unique charms (“harmony without uniformity, and beauty in diversity”).

    “The Golden Panda Awards can leverage the power of images to inspire creativity, convey beauty, promote inclusiveness, and enhance understanding and resonance among people of all countries,” stated Ahmed, Egyptian Minister of Culture, at the Golden Panda International Cultural Forum. He pointed out that exchanges and dialogues between civilizations are an inevitable choice for humanity in the face of global challenges.

    The Golden Panda Awards eliminate barriers and break down prejudices. Through them, people not only perceive the diversity of civilizations and the vastness of the world, but also witness the authenticity of individuals and the vividness of subtle details. Hannatu Musawa, Minister of Art, Culture, Tourism and Creative Economy of the Federal Republic of Nigeria, noted that the world often views Africa through a one-sided lens, but now Africa is taking the initiative to tell its own stories. “I sincerely appreciate China’s efforts in amplifying Africa’s voice, enabling our stories to reach the world in a clearer and more profound manner.”

    Over the 130 years since the birth of film and the 100 years since the invention of television, tremendous changes have taken place in how people watch videos, the technologies used in filming, and the audience groups. Artificial intelligence is now deeply involved in the film industry chain. However, during the Golden Panda Awards, filmmakers from around the world unanimously emphasized the need to “return”—to return to the essence of cinema: films are made for people and touch hearts with emotions.

    In the view of Hussein Fahmy, a guest of the Golden Panda Awards and Chairman of the Cairo International Film Festival, although some current films feature breathtaking scenes (such as characters flying through the sky and traversing the earth) and various stunning special effects, if technology is only used as a gimmick to grab attention, such works will hardly resonate with audiences from both the East and the West. Films that can arouse empathy among Eastern and Western audiences must have characters that both groups can relate to, making viewers feel as if they have experienced the characters’ lives firsthand.

    Vincent Perez, a renowned Swiss actor and director, quoted a Swiss proverb—”Where the heart is, the tongue will follow”—at the Golden Panda International Cultural Forum to encourage global filmmakers to be the actors, writers and directors of their own lives, and create touching works at the intersection of Eastern and Western civilizations. Citing Western Turandot and Chinese Ye Xian as examples, he pointed out that although many classic stories originate from different backgrounds, they transcend cultural boundaries and are passed down worldwide due to the shared pursuit of emotion, beauty and hope.

    Perhaps, as Chen Kaige, Chairman of the Jury for the 2nd Golden Panda Awards and a Chinese director, put it, the Golden Panda Awards are precisely meant to build a bridge, making exchanges and mutual learning tangible. “We are all torchbearers, using the camera as our language. Every sincere work is a reflection and response to the destiny of humanity.” Chen Kaige added, “When thousands of rivers converge and ten thousand lights shine on one another, what we see will no longer be ‘you’ or ‘me’, but a shared spiritual home that belongs to all mankind.” (End)

    Golden Panda Awards Gala Held in Chengdu on the Evening of the 13th; Nezha 2 Wins Best Animation Award    Photo by An Yuan, Reporter of China News Service

    Hussein Fahmy, President of the Cairo International Film Festival and Guest of the Golden Panda Awards         Photo by An Yuan, Reporter of China News Service

  • LLVision Unveils Leion Hey2 AR Translation Glasses at IFA 2025

    Lightweight, all-day design delivers two-way, real-time translation in 100+ languages

    BERLIN, GERMANY – LLVision unveiled Leion Hey2, its next-generation AR translation glasses, at IFA 2025. Designed for everyday, face-to-face conversations, Leion Hey2 brings real-time subtitling to a lightweight, wear-all-day form factor.

    Building on IFA’s “Imagine the Future” theme, LLVision highlighted advances in optics, AI and human–computer interaction. Leion Hey2 is built to remove language barriers and make multilingual conversations feel natural across daily and professional settings.

    At 49g, Leion Hey2 features a classic browline silhouette and self-adjusting spring hinges for a secure, comfortable fit across face shapes. A refined mix of gloss and matte finishes makes it suitable for everyday wear.

    LLVision’s proprietary optical engine uses ultra-thin 0.4 mm lenses that remain bright enough for subtitles in direct sunlight. An advanced anti-glare treatment reduces chromatic aberration for clear, stable text.

    Real-time translation is core to Leion Hey2: it supports two-way translation in 100+ languages and dialects, with latency under 500 ms and accuracy up to 98%, depending on environment. A 360-degree spatial audio system and neural-network noise reduction separate speakers, filter background noise and enable voiceprint recognition in busy spaces study-abroad classrooms and cross-language meetings. The result is a practical tool for travel, international business and multilingual teamwork.

    Leion Hey2 delivers up to 8 hours of continuous use per charge. The compact charging case holds up to 12 additional charges—providing as much as 96 hours of total use for multi-day trips.

    The built-in Hey Agent lets users control the device by voice, access information in real time and auto-generate multilingual meeting notes. It understands natural speech—including slang and industry terms—for both professional and everyday scenarios.

    “Technology should foster inclusive, human connection, ” said Roy Lou, chief operating officer at LLVision. “With Leion Hey2, we show how AI and AR can make cross-language and cross-cultural communication feel effortless and intuitive.”

    Social Links

    TikTok: tiktok.com/@leion_global

    YouTube: https://youtube.com/@leion_global?si=AJPWVswv72kKgCfp

    LinkedIn: https://www.linkedin.com/in/lousq/

    Media Contact

    Brand / Company Name: LEION Hey / LLVision

    Contact: Roy LOU, COO

    Telephone: +65 98851629

    Email: lousq@llvision.com

    Website: https://leion.llvision.com

    Address (with Postcode)

    65 Chulia Street, #25-03 OCBC Centre, Singapore 049513

    501, 5th Floor, Building 8, No. 10 Kegu 1st Street, Beijing Economic and Technological Development Zone, Beijing, China